SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Critical Review of European Health-Economic Guidelines for the Health Technology Assessment of Medical Devices
16 references·0 citing·37 second hop
Critical Review of European Health-Economic Guidelines for the Health Technology Assessment of Medical Devices (2019)Critical Review of European Health-Econom…HEALTH TECHNOLOGY ASSESSMENT METHODS GUIDELINES FOR MEDICAL DEVICES: HOW CAN WE ADDRESS THE GAPS? THE INTERNATIONAL FEDERATION OF MEDICAL AND BIOLOGICAL ENGINEERING PERSPECTIVE (2018)HEALTH TECHNOLOGY ASSESSMENT …Health technology assessment (HTA) and economic evaluation: efficiency or fairness first (2018)Health technology assessment …Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries (2017)Using health technology asses…Key Recommendations from the MedtecHTA Project (2017)Key Recommendations from the …Improving the Methods for the Economic Evaluation of Medical Devices (2017)Improving the Methods for the…Characterising Uncertainty in the Assessment of Medical Devices and Determining Future Research Needs (2017)Characterising Uncertainty in…Challenges in the Assessment of Medical Devices: The MedtecHTA Project (2017)Challenges in the Assessment …A bias‐adjusted evidence synthesis of RCT and observational data: the case of total hip replacement (2017)A bias‐adjusted evidence synt…Development of an Official Guideline for the Economic Evaluation of Drugs/Medical Devices in Japan (2016)Development of an Official Gu…Health technology assessment of medical devices: What is different? An overview of three European projects (2015)Health technology assessment …The Economic Evaluation of Medical Devices (2013)The Economic Evaluation of Me…Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Preferred Reporting Items for…Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred reporting items for…Economic Evaluation for Devices and Drugs—Same or Different? (2008)Economic Evaluation for Devic…Assessing the Clinical and Cost-Effectiveness of Medical Devices and Drugs: Are They That Different? (2008)Assessing the Clinical and Co…Measuring Preferences for Cost-Utility Analysis (2007)Measuring Preferences for Cos…Methods for the Economic Evaluation of Health Care Programmes (2005)Methods for the economic evaluation of health care programmes, 3rd ed (2006)De innovatione: The concept of innovation for medical technologies and its implications for healthcare policy-making (2015)HEALTH TECHNOLOGY ASSESSMENT OF MEDICAL DEVICES: A SURVEY OF NON-EUROPEAN UNION AGENCIES (2015)The European Commission (2015)Linking the Regulatory and Reimbursement Processes for Medical Devices: The Need for Integrated Assessments (2017)Cost-Effectiveness in Health and Medicine (1996)Combination of direct and indirect evidence in mixed treatment comparisons (2004)Medical technology procurement in Europe: A cross-country comparison of current practice and policy (2010)HEALTH TECHNOLOGY ASSESSMENT, VALUE-BASED DECISION MAKING, AND INNOVATION (2013)EuroQol: the current state of play (1996)Is The United States Ready For QALYs? (2009)Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD) (2014)Lifestyle Interventions to Prevent Type 2 Diabetes: A Systematic Review of Economic Evaluation Studies (2016)Statistical assessment of the learning curves of health technologies (2001)Bayesian Methods for Evidence Synthesis in Cost-Effectiveness Analysis (2006)The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies (2007)The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration (2009)PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation (2018)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021)EuroQol - a new facility for the measurement of health-related quality of life (1990)A Health Economics Approach to US Value Assessment Frameworks—Introduction: An ISPOR Special Task Force Report [1] (2018)Formal Implementation of Cost-Effectiveness Evaluations in Japan: A Unique Health Technology Assessment System (2019)Current Development and Practice of Pharmacoeconomic Evaluation Guidelines for Universal Health Coverage in China (2020)Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (2013)A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) (2015)American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options (2015)Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold (2015)Multiple Criteria Decision Analysis (MCDA) for evaluating new medicines in Health Technology Assessment and beyond: The Advance Value Framework (2017)Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward (2019)A Health Opportunity Cost Threshold for Cost-Effectiveness Analysis in the United States (2020)Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement (1999)The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (2001)Automated hospital pharmacy supply chain and the evaluation of organisational impacts and costs (2020)Establishing a national HTA program for medical devices in Italy: Overhauling a fragmented system to ensure value and equal access to new medical technologies (2021)The Value of Health in a Cost-Effectiveness Analysis: Theory Versus Practice (2023)
this work references cited by second hop

References

  • 2009Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement84,364 cited
  • 2009Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement65,829 cited
  • 2017Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries306 cited
  • 2008Economic Evaluation for Devices and Drugs—Same or Different?237 cited
  • 2016Development of an Official Guideline for the Economic Evaluation of Drugs/Medical Devices in Japan154 cited
  • 2007Measuring Preferences for Cost-Utility Analysis113 cited
  • 2017Challenges in the Assessment of Medical Devices: The MedtecHTA Project102 cited
  • 2017Improving the Methods for the Economic Evaluation of Medical Devices80 cited
  • 2008Assessing the Clinical and Cost-Effectiveness of Medical Devices and Drugs: Are They That Different?79 cited
  • 2013The Economic Evaluation of Medical Devices72 cited
  • 2017Characterising Uncertainty in the Assessment of Medical Devices and Determining Future Research Needs71 cited
  • 2017Key Recommendations from the MedtecHTA Project69 cited
  • 2015Health technology assessment of medical devices: What is different? An overview of three European projects51 cited
  • 2018Health technology assessment (HTA) and economic evaluation: efficiency or fairness first

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

51 cited
  • 2018HEALTH TECHNOLOGY ASSESSMENT METHODS GUIDELINES FOR MEDICAL DEVICES: HOW CAN WE ADDRESS THE GAPS? THE INTERNATIONAL FEDERATION OF MEDICAL AND BIOLOGICAL ENGINEERING PERSPECTIVE50 cited
  • 2017A bias‐adjusted evidence synthesis of RCT and observational data: the case of total hip replacement26 cited
  • Cited by

    No citing works inside the corpus for this window.